from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2847c/cysG

LFCtreatmentdescriptionclass of inhibitor

-0.674

Amikacinug/mL Amikacintranslation

-0.960

Cap5-10ug/mL Capreomycintranslation

-1.191

Rox10-50 ug/mL Roxithromycintranslation

-0.335

SM2-5 ug/mL Streptomycintranslation

-1.561

Tet5-10 ug/mL Tetracyclinetranslation

0.733

Rif0.2-5ug/mL Rifampicintranscription

-0.664

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.137

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.909

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.439

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.657

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.428

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.249

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.824

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.768

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.915

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.689

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.080

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.246

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.477

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.207

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.398

Nigericin50 uM Nigericinrespiration

1.026

TRC10-150 ug/mL Triclosanrespiration

-1.481

TRZ10-25 ug/mL Thioridazinerespiration

-0.344

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.212

menadione6-10 ug/mL Menadionerespiration

0.104

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.233

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.330

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.672

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.084

NRP_1Non-replicating persistence stage 1dosRassociated

-0.127

Amp0.2mg/mL AmpicillincellWall

-0.292

Cephalexin20-100 ug/mL CephalexincellWall

0.420

Cerulenin0.32-5 ug/mL CerulenincellWall

0.143

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.072

EMB10-20 ug/mL EthambutolcellWall

0.349

Eta12-40 ug/mL EthionamidecellWall

0.259

INH0.2-0.4 ug/mL IsoniazidcellWall

0.360

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.740

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.468

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.334

BZA0.12 mg/mL BenzamidearomaticAmides

0.094

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.467

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.879

H2O24 mM hydrogen peroxideDNAdamaging

0.011

Levo10 ug/mL LevofloxacinDNAdamaging

-0.344

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.294

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.073

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.430

UVUV-irradiationDNAdamaging

0.237

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.064

Antimycin12.5-50 ug/mL Antimycin A?

-0.347

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.036

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.016

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.539

PA8240.2-2 ug/mL PA-824?

0.927

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.735

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.906

Verapamil50 uM Verapamil?

-0.412

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.168

methoxatin10-20 ug/mL Methoxatin?